Description of the plasminogen activating system in canine gingival crevicular fluid

Fibrinolysis and Proteolysis

Volumn 14, Issue 6, 2000, Pages 337-342

  Lindberg, P ^a,b   Kinnby, B ^a   Lecander, I ^a   Matsson, L ^b  

^a MALMÖ UNIVERSITY   (Sweden)

^b MALMÖ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN DETECTION; ARTICLE; CHRONIC DISEASE; COMPLEX FORMATION; CONTROLLED STUDY; CROSS REACTION; DOG; FEMALE; FIBRINOLYSIS; GINGIVITIS; MOLECULAR WEIGHT; NONHUMAN; PERIODONTAL DISEASE; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN LOCALIZATION; WESTERN BLOTTING;

EID: 0034525586     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1054/fipr.2000.0091     Document Type: Article

References (34)

1. Egelberg J. The blood vessels of the dento-gingival junction. J Periodont Res 1966; 1: 163-179.
2. Gustafsson GT, Nilsson IM. Fibrinolytic activity in fluid from gingival crevice. Proc Soc Exp Biol Med 1961; 106: 277-280.
3. Kinnby B, Lecander I, Martinsson G, Åstedt B. Tissue plasminogen activator and placental plasminogen activator inhibitor in human gingival fluid. Fibrinolysis 1991; 5: 239-242.
4. Schmid J, Cohen RL, Chambers DA. Plasminogen activators in human periodontal health and disease. Short communication. Arch Oral Biol 1991; 36: 245-250.
5. Hidaka N, Maeda K, Kawakami C, Aono M, Okada H. Fibrinolytic activity in periodontal disease. The relationship between fibrinolytic activity and severity of periodontal disease. J Periodontol 1981; 52: 181-186.
6. Werb Z, Mainardi C, Vater CA, Harris ED. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N Engl J Med 1977; 296: 1017-1023.
7. Matrisian M. The matrix-degrading metalloproteinases. BioEssays 1992; 14: 455-463.
8. Åstedt B. No crossreaction between circulating plasminogen activator and urokinase. Thromb Res 1978; 14: 535-539.
9. Rømer J, Lund LR, EriksenJ, Kristensen P, Danø K. The receptor for urokinase-type plasminogen activator is expressed by keratinocytes at the leading edge during reepithelialization of mouse skin wounds. J Invest Dermatol 1994; 102: 519-522.
10. Quax PHA, Boxman ILA, van Kesteren CAM, Verheijen JH, Ponec M. Plasminogen activators are involved in keratinocyte and fibroblast migration in wounded cultures in vitro. Fibrinolysis 1994; 8: 221-228.
11. Jensen PJ, Lavker LM. Modulation of the plasminogen activator cascade during enhanced epidermal proliferation in vivo. Cell Growth Differ 1995; 12: 1793-1804.
12. Saksela O, Hovi T, Vaheri A. Urokinase-type plasminogen activator and its inhibitor secreted by cultured human monocyte-macrophages. J Cell Physiol 1985; 122: 125-132.
13. Hart PH, Vitti GF, Burgess DR, Singleton DK, Hamilton JA. Human monocytes can produce tissue-type plasminogen activator. J Exp Med 1989; 169: 1509-1514.
14. Kramer MD, Schaefer B, Reinartz J. Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences. Biol Chem Hoppe-Seyler 1995; 376: 131-141.
15. Kinnby B, Lindberg P, Lecander I, Matsson L. Localization of plasminogen activators and plasminogen activator inhibitors in human gingival tissue demonstrated by immunohistochemistry and in situ hybridization. Arch Oral Biol 1999; 44: 1027-1034.
16. Åstedt B, Hägerstrand I, Lecander I. Cellular localisation in placenta of placental type plasminogen activator inhibitor. Thromb Haemost 1986; 56: 63-65.
17. Vassalli JD, Dayer JM, Wohlwend A, Belin D. Concomitant secretion of pro-urokinase and of a plasminogen activator-specific inhibitor by cultured human monocytes-macrophages. J Exp Med 1984; 159: 1653-1668.
18. Chapman Jr HA, Stone OL. Characterization of a macrophage derived plasminogen-activator inhibitor. Similarities with placental urokinase inhibitor. Biochem J 1985; 230: 109-116.
19. Danø K, Rømer J, Nielsen BS, Bjorn S, Pyke C, Rygaard J, Lund LR. Cancer invasion and tissue remodelling - cooperation of protease systems and cell types. APMIS 1999; 107: 120-127.
20. Thorsen S, Philips M. Plasminogen activator inhibitors. In: Castellino et al. (eds) Fundamental and clinical fibrinolysis. London: Elsevier Science Publishers, 1987; 83-98.
21. Kinnby B, Borgström Krasse M, Granath L, Lecander I. Sundin B. Tissue plasminogen activator (t-PA) and placental plasminogen
22. Kinnby B, Matsson L, Lecander I. The Plasminogen-activating system in gingival fluid from adults. An intra-individual study before and after treatment of gingivitis. Scand J Dent Res 1994; 102: 334-341.
23. Kinnby B, Matsson L, Åstedt B. Aggravation of gingival inflammatory symptoms during pregnancy associated with the concentration of plasminogen activator inhibitor type 2 (PAI-2) in gingival fluid. J Periodont Res 1996; 31: 271-277.
24. Lindhe J, Hamp SH, Löe H. Experimental periodontis in the Beagle dog. J Periodont Res 1973; 8: 1-10.
25. Ericsson I, Lindhe J, Rylander H, Okamota H. Experimental periodontal breakdown in the dog. Scand J Dent Res 1975; 83: 189-192.
26. Matsson L, Attström R. Development of experimental gingivitis in the juvenile and adult Beagle dog. Test of a model for comparative studies. J Clin Periodont 1979a; 6: 186-193.
27. Groisman M, Klinge B. Clinical and histological findings in ligature-induced experimental periodontitis in dogs. A pilot study. J Clin Periodontol 1990; 17: 186-190.
28. Löe H. The Gingival Index, the Plaque Index and the Retention Index system. J Periodont 1967; 38: 610-616.
29. Lecander I, Åstedt B. Occurrence of a specific plasminogen activator inhibitor of placental type, PAI-2, in men and non-pregnant women. Fibrinolysis 1989; 3: 27-30.
30. Sidelman J, Jespersen J, Gram J. Plasminogen activator activity and plasma-coagulum lysis measured by use of optimized fibrin gel structure preformed in rnicrotiter plates. Clin Chem 1995; 41:979-985.
31. Häggroth L, Mattsson C, Friberg J. Inhibition of the human tissue plasminogen activator in plasma from different species. Thromb Res 1984; 33: 583-594.
32. Lanevschi A, Kramer JW, Green SA, Meyers KM. Evaluation of chromogenic substrate assays for fibrinolytic analyses in dogs. Am J Vet Res 1996; 57: 1124-1130.
33. Brown JM, Watanabe K, Cohen RL, Chambers DA. Molecular characterization of plasminogen activators in human gingival crevicular fluid. Arch Oral Biol 1995; 40: 839-845.
34. Cohen RL, Watanabe K, Schmid J, Brown JM, Chambers DA. Plasminogen activator in periodontal health and disease. Ann NY Acad Sci 1992; 667: 183-185.